Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway

    ... The effects of erythropoietin on osteoblasts and bone formation are controversially ... myelodysplastic syndromes often display excessively high erythropoietin level, we aimed to analyze the effect of erythropoietin on ...

    Research Article last updated 11/08/2017 - 8:52am.

  2. Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes

    Journal Title:  Haematologica Primary Author:  Cluzeau T Author(s):  Cluzeau ...

    Research Article last updated 10/20/2017 - 9:16am.

  3. Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes

    ... the disease. Here we show effects of recombinant human erythropoietin (rHuEPO) on T cell (CD4+, CD8+ and CD4+CD25+) number ...

    Research Article last updated 12/09/2016 - 3:05pm.

  4. Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors

    ... erythropoiesis-stimulating agents (ESAs) such as erythropoietin (EPO) and mimetics are applied as first-line therapy in a ...

    Research Article last updated 10/23/2017 - 11:08am.

  5. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... restores effective erythropoiesis via enhancement of erythropoietin (EPO) receptor-initiated transcriptional response arising ...

    Research Article last updated 10/23/2017 - 10:58am.

  6. Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

    ... of treatment with deferasirox combined with erythropoietin vs. erythropoietin alone on erythropoiesis in patients with low- and ...

    Clinical Trial last updated 04/27/2016 - 12:52pm.

  7. Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors

    ... erythropoiesis-stimulating agents (ESAs) such as erythropoietin (EPO) and mimetics are applied as first-line therapy in a ...

    Research Article last updated 10/02/2017 - 10:10am.

  8. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... restores effective erythropoiesis via enhancement of erythropoietin (EPO) receptor-initiated transcriptional response arising ...

    Research Article last updated 10/02/2017 - 9:54am.

  9. Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes

    ... Low endogenous erythropoietin levels and limited red blood cell transfusion ...

    Research Article last updated 08/04/2014 - 8:33am.

  10. Foundation Update - April 2016

    ... as relatively low risk. I have been treated with erythropoietin (Procrit®), G-CSF, (Neupogen®), azacitidine , ...

    Article last updated 10/09/2017 - 2:57pm.